Kokaina i układ odpornościowy - Instytut Psychiatrii i Neurologii

M.M. Jankowski, B. Ignatowska-Jankowska, K. Kumański, A. Kamińska, A.H. Świergiel
91. Baldwin GC, Tashkin DP, Buckley DM, Park AN, Dubinett SM, Roth MD (1997) Marijuana and
cocaine impair alveolar macrophage function and cytokine production. American Journal of Respiratory
and Critical Care Medicine, 156, 1606–1613.
92. Ruiz P, Cleary T, Nassiri M, Steele B (1994) Human T lymphocyte subpopulation and NK cell alterations
in persons exposed to cocaine. Clinical Immunology and Immunopathology, 70, 245–250.
93. Ruiz P, Berho M, Steele BW, Hao L (1998) Peripheral human T lymphocyte maintenance of
immune functional capacity and phenotypic characteristics following in vivo cocaine exposure.
Clinical Immunology and Immunopathology, 88, 271–276.
94. Van Dyke C, Stesin A, Jones R, Chuntharapai A, Seaman W (1986) Cocaine increases natural killer
cell activity. Journal of Clinical Investigation, 77, 1387–1390.
95. Siddiqui NS, Brown LS Jr, Makuch RW (1993) Short-term declines in CD4 levels associated with
cocaine use in HIV-1 seropositive, minority injecting drug users. Journal of the National Medical
Association, 85, 293–296.
Adres do korespondencji
Artur H. Świergiel
ul. Nowogrodzka 62B/31, 02-002 Warszawa
tel. (48) 503 934 080
e-mail: psychoimmunolgia@yahoo.com
Otrzymano: 29.08.2011
Przyjęto do druku: 30.04.2012
214